A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells

A family of compounds with the general formula [Fe(η<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)(CO)(PPh<sub>3</sub>)(NCR)]<sup>+</sup> has been synthesized (NCR = benzonitrile (<b>1</b>); 4-hydroxybenzonitrile (<b>2</b>...

Full description

Bibliographic Details
Main Authors: Adhan Pilon, Ana Rita Brás, Leonor Côrte-Real, Fernando Avecilla, Paulo J. Costa, Ana Preto, M. Helena Garcia, Andreia Valente
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/7/1592
id doaj-13705ff2ed634604983942486faea1e0
record_format Article
spelling doaj-13705ff2ed634604983942486faea1e02020-11-25T02:05:23ZengMDPI AGMolecules1420-30492020-03-01251592159210.3390/molecules25071592A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer CellsAdhan Pilon0Ana Rita Brás1Leonor Côrte-Real2Fernando Avecilla3Paulo J. Costa4Ana Preto5M. Helena Garcia6Andreia Valente7Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalGrupo Xenomar, Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Química, Facultade de Ciencias, Universidade da Coruña, Campus de A Coruña, 15071 A Coruña, SpainFaculty of Sciences, University of Lisboa, BioISI—Biosystems & Integrative Sciences Institute, Campo Grande, C8 bdg, 1749-016 Lisboa, PortugalCentre of Molecular and Environmental Biology, Department of Biology, University of Minho, Campus de Gualtar, 4710-057 Braga, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalA family of compounds with the general formula [Fe(η<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)(CO)(PPh<sub>3</sub>)(NCR)]<sup>+</sup> has been synthesized (NCR = benzonitrile (<b>1</b>); 4-hydroxybenzonitrile (<b>2</b>); 4-hydroxymethylbenzonitrile (<b>3</b>); 4-aminobenzonitrile (<b>4</b>); 4-bromobenzonitrile (<b>5</b>); and, 4-chlorocinnamonitrile (<b>6</b>)). All of the compounds were obtained in good yields and were completely characterized by standard spectroscopic and analytical techniques. Compounds <b>1</b>, <b>4</b>, and <b>5</b> crystallize in the monoclinc P21/c space group and packing is determined by short contacts between the phosphane phenyl rings and cyclopentadienyl (compounds <b>1</b> and <b>4</b>) or π-π lateral interactions between the benzonitrile molecules (complex <b>5</b>). DFT and TD-DFT calculations were performed to help in the interpretation of the experimental UV-Vis. data and assign the electronic transitions. Cytotoxicity studies in MDA-MB-231 breast and SW480 colorectal cancer-derived cell lines showed IC<sub>50</sub> values at a low micromolar range for all of the compounds in both cell lines. The determination of the selectivity index for colorectal cells (SW480 vs. NCM460, a normal colon-derived cell line) indicates that the compounds have some inherent selectivity. Further studies on the SW480 cell line demonstrated that the compounds induce cell death by apoptosis, inhibit proliferation by inhibiting the formation of colonies, and affect the actin-cytoskeleton of the cells. These results are not observed for the hydroxylated compounds <b>2</b> and <b>3</b>, where an alternative mode of action might be present. Overall, the results indicate that the substituent at the nitrile-based ligand is associated to the biological activity of the compounds.https://www.mdpi.com/1420-3049/25/7/1592iron(II)-cyclopentadienylnitrile-based ligandscolorectal cancertriple negative breast cancer
collection DOAJ
language English
format Article
sources DOAJ
author Adhan Pilon
Ana Rita Brás
Leonor Côrte-Real
Fernando Avecilla
Paulo J. Costa
Ana Preto
M. Helena Garcia
Andreia Valente
spellingShingle Adhan Pilon
Ana Rita Brás
Leonor Côrte-Real
Fernando Avecilla
Paulo J. Costa
Ana Preto
M. Helena Garcia
Andreia Valente
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
Molecules
iron(II)-cyclopentadienyl
nitrile-based ligands
colorectal cancer
triple negative breast cancer
author_facet Adhan Pilon
Ana Rita Brás
Leonor Côrte-Real
Fernando Avecilla
Paulo J. Costa
Ana Preto
M. Helena Garcia
Andreia Valente
author_sort Adhan Pilon
title A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
title_short A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
title_full A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
title_fullStr A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
title_full_unstemmed A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
title_sort new family of iron(ii)-cyclopentadienyl compounds shows strong activity against colorectal and triple negative breast cancer cells
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2020-03-01
description A family of compounds with the general formula [Fe(η<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)(CO)(PPh<sub>3</sub>)(NCR)]<sup>+</sup> has been synthesized (NCR = benzonitrile (<b>1</b>); 4-hydroxybenzonitrile (<b>2</b>); 4-hydroxymethylbenzonitrile (<b>3</b>); 4-aminobenzonitrile (<b>4</b>); 4-bromobenzonitrile (<b>5</b>); and, 4-chlorocinnamonitrile (<b>6</b>)). All of the compounds were obtained in good yields and were completely characterized by standard spectroscopic and analytical techniques. Compounds <b>1</b>, <b>4</b>, and <b>5</b> crystallize in the monoclinc P21/c space group and packing is determined by short contacts between the phosphane phenyl rings and cyclopentadienyl (compounds <b>1</b> and <b>4</b>) or π-π lateral interactions between the benzonitrile molecules (complex <b>5</b>). DFT and TD-DFT calculations were performed to help in the interpretation of the experimental UV-Vis. data and assign the electronic transitions. Cytotoxicity studies in MDA-MB-231 breast and SW480 colorectal cancer-derived cell lines showed IC<sub>50</sub> values at a low micromolar range for all of the compounds in both cell lines. The determination of the selectivity index for colorectal cells (SW480 vs. NCM460, a normal colon-derived cell line) indicates that the compounds have some inherent selectivity. Further studies on the SW480 cell line demonstrated that the compounds induce cell death by apoptosis, inhibit proliferation by inhibiting the formation of colonies, and affect the actin-cytoskeleton of the cells. These results are not observed for the hydroxylated compounds <b>2</b> and <b>3</b>, where an alternative mode of action might be present. Overall, the results indicate that the substituent at the nitrile-based ligand is associated to the biological activity of the compounds.
topic iron(II)-cyclopentadienyl
nitrile-based ligands
colorectal cancer
triple negative breast cancer
url https://www.mdpi.com/1420-3049/25/7/1592
work_keys_str_mv AT adhanpilon anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT anaritabras anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT leonorcortereal anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT fernandoavecilla anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT paulojcosta anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT anapreto anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT mhelenagarcia anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT andreiavalente anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT adhanpilon newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT anaritabras newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT leonorcortereal newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT fernandoavecilla newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT paulojcosta newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT anapreto newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT mhelenagarcia newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
AT andreiavalente newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells
_version_ 1724938302977474560